Long-term safety of ustekinumab for psoriasis

Author： Kumar Neal   Narang Kirti   Cressey Brienne D   Gottlieb Alice B  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.12, Iss.5, 2013-09, pp. : 757-765

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biologicals for psoriasis showing promise in long-term treatment

By  

Inpharma, Vol. 1, Iss. 1304, 2001-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Ustekinumab proves positive for psoriasis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Safety concerns with the long-term management of osteoporosis

By Reginster Jean-Yves  

Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. : 507-522

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of long-term bisphosphonates in postmenopausal osteoporosis

By Miller Paul D  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2253-2258

Informa Healthcare

Access to resources Recommend Favorite

Long-term safety of tacrolimus ointment in atopic dermatitis

By Remitz Anita   Reitamo Sakari  

Expert Opinion on Drug Safety, Vol. 8, Iss. 4, 2009-07 ,pp. : 501-506

Informa Healthcare

Access to resources Recommend Favorite